يعرض 1 - 10 نتائج من 57 نتيجة بحث عن '"Lee, Elizabeth K"', وقت الاستعلام: 1.88s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المصدر: Yap , T A , Fontana , E , Lee , E K , Spigel , D R , Højgaard , M , Lheureux , S , Mettu , N B , Carneiro , B A , Carter , L , Plummer , R , Cote , G M , Meric-Bernstam , F , O’Connell , J , Schonhoft , J D , Wainszelbaum , M , Fretland , A J , Manley , P , Xu , Y , Ulanet , D , Rimkunas , V , Zinda , M , Koehler , M , Silverman , I ....

  4. 4
    دورية أكاديمية

    المساهمون: University of Minnesota Duluth

    المصدر: Psychological Trauma: Theory, Research, Practice, and Policy ; volume 16, issue Suppl 1, page S302-S312 ; ISSN 1942-969X 1942-9681

  5. 5
  6. 6
    دورية أكاديمية

    المساهمون: Research Program in Systems Oncology, Department of Obstetrics and Gynecology, HUS Gynecology and Obstetrics

    وصف الملف: application/pdf

    العلاقة: We thank the patients and their families for their participation in this study. This study was funded by the NCI-Cancer Therapy Evaluation Program (CTEP) and conducted under the auspices of the Experimental Therapeutics Clinical Trials Network (ETCTN). Dana-Farber/Harvard Cancer Center served as the lead site for the study, supported by NIH grant UM1 CA186709 (G.I.S., Principal Investigator). This work was also funded by Supplements to UM1 CA186709 for the development of immunohistochemical biomarkers for homologous recombination repair and ATM proficiency (B.K., A.D.D., and G.I.S.) and by the Dana-Farber/Harvard Cancer Center Specialized Program of Research Excellence (SPORE) (P50CA240243) in Ovarian Cancer (P.A.K., B.K., J.F.L., N.T., U.A.M., A.D.D., and G.I.S.).; Konstantinopoulos , P A , da Costa , A A B A , Gulhan , D , Lee , E K , Cheng , S-C , Hendrickson , A E W , Kochupurakkal , B , Kolin , D L , Kohn , E C , Liu , J F , Stover , E H , Curtis , J , Tayob , N , Polak , M , Chowdhury , D , Matulonis , U A , Färkkilä , A , D'Andrea , A D & Shapiro , G 2021 , ' A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer ' , Nature Communications , vol. 12 , no. 1 , 5574 . https://doi.org/10.1038/s41467-021-25904-wTest; e0d06ff9-4e70-47ca-bbac-1162e2726c17; http://hdl.handle.net/10138/336193Test; 000700360600009

  7. 7
  8. 8
    كتاب

    المؤلفون: Lee, Elizabeth K., Liu, Joyce F.

    المصدر: Targeting the DNA Damage Response for Cancer Therapy ; Cancer Treatment and Research ; page 171-188 ; ISSN 0927-3042 2509-8497 ; ISBN 9783031300646 9783031300653

  9. 9
    دورية أكاديمية

    المصدر: Therapeutic Advances in Medical Oncology ; volume 12, page 175883592094411 ; ISSN 1758-8359 1758-8359

    مصطلحات موضوعية: Oncology

  10. 10
    دورية أكاديمية

    المساهمون: Entertainment Industry Foundation, American Association for Cancer Research, National Cancer Institute, Miriam and Sheldon Adelson Medical Research Foundation, Ovarian Cancer Research Foundation, The Breast Cancer Research Foundation, Prospect Creek Foundation, Komen Foundation, NCI, National Institutes of Health, Stand Up To Cancer Colorectal Cancer Dream Team Translational Research, Eisai, Merck, Genentech, AbbVie

    المصدر: Gynecologic Oncology Reports ; volume 32, page 100546 ; ISSN 2352-5789

    مصطلحات موضوعية: Obstetrics and Gynecology, Oncology